Using published microarray-based expression data from breast cancer patients [35], [37] we employed a previously described gene set enrichment analysis (GSEA) approach to assess whether the gene expression profile of a patient is enriched in low and/or high cooperativity p53 target genes [38]. The gene discussed is TP53; the disease is breast carcinoma.